Zymenex develops pharmaceutical products to treat rare, serious and genetic diseases. The company’s goal is to develop a successive number of enzyme replacement therapies for diseases, which may have an orphan drug potential.
If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact firstname.lastname@example.org or +45 5150 0560
Copyright 2010 Danskbiotek. All rights reserved.
created by: Mastafu Design